nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—Non-cardiac chest pain—Telbivudine—hepatitis B	0.0641	0.0651	CcSEcCtD
Sitagliptin—Sciatica—Telbivudine—hepatitis B	0.0389	0.0395	CcSEcCtD
Sitagliptin—Sinus headache—Telbivudine—hepatitis B	0.0341	0.0347	CcSEcCtD
Sitagliptin—Serum creatinine increased—Entecavir—hepatitis B	0.022	0.0224	CcSEcCtD
Sitagliptin—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0215	0.0218	CcSEcCtD
Sitagliptin—Hepatic steatosis—Lamivudine—hepatitis B	0.0208	0.0211	CcSEcCtD
Sitagliptin—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0165	0.0167	CcSEcCtD
Sitagliptin—Laryngeal pain—Telbivudine—hepatitis B	0.0163	0.0166	CcSEcCtD
Sitagliptin—Fungal skin infection—Lamivudine—hepatitis B	0.015	0.0152	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Telbivudine—hepatitis B	0.0113	0.0114	CcSEcCtD
Sitagliptin—Neck pain—Telbivudine—hepatitis B	0.0113	0.0114	CcSEcCtD
Sitagliptin—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.0101	0.0102	CcSEcCtD
Sitagliptin—Respiratory tract infection—Lamivudine—hepatitis B	0.00997	0.0101	CcSEcCtD
Sitagliptin—Blood creatinine increased—Entecavir—hepatitis B	0.00921	0.00935	CcSEcCtD
Sitagliptin—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00898	0.00913	CcSEcCtD
Sitagliptin—Abdominal pain upper—Entecavir—hepatitis B	0.00898	0.00912	CcSEcCtD
Sitagliptin—Renal impairment—Telbivudine—hepatitis B	0.00848	0.00862	CcSEcCtD
Sitagliptin—Pancreatitis—Entecavir—hepatitis B	0.00833	0.00846	CcSEcCtD
Sitagliptin—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00812	0.00826	CcSEcCtD
Sitagliptin—Pain in extremity—Telbivudine—hepatitis B	0.00807	0.0082	CcSEcCtD
Sitagliptin—Migraine—Telbivudine—hepatitis B	0.00795	0.00807	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Entecavir—hepatitis B	0.00789	0.00802	CcSEcCtD
Sitagliptin—Hyperglycaemia—Entecavir—hepatitis B	0.00766	0.00778	CcSEcCtD
Sitagliptin—Renal failure—Entecavir—hepatitis B	0.00744	0.00756	CcSEcCtD
Sitagliptin—Abdominal pain upper—Telbivudine—hepatitis B	0.00737	0.00749	CcSEcCtD
Sitagliptin—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00726	0.00738	CcSEcCtD
Sitagliptin—Nasopharyngitis—Telbivudine—hepatitis B	0.00722	0.00733	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Entecavir—hepatitis B	0.00716	0.00728	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00699	0.0071	CcSEcCtD
Sitagliptin—Influenza—Telbivudine—hepatitis B	0.00698	0.00709	CcSEcCtD
Sitagliptin—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00693	0.00704	CcSEcCtD
Sitagliptin—Oedema peripheral—Entecavir—hepatitis B	0.0067	0.0068	CcSEcCtD
Sitagliptin—Abdominal discomfort—Telbivudine—hepatitis B	0.00669	0.0068	CcSEcCtD
Sitagliptin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00658	0.00669	CcSEcCtD
Sitagliptin—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00655	0.00666	CcSEcCtD
Sitagliptin—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00652	0.00662	CcSEcCtD
Sitagliptin—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0065	0.00661	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00648	0.00659	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Lamivudine—hepatitis B	0.00634	0.00645	CcSEcCtD
Sitagliptin—Immune system disorder—Entecavir—hepatitis B	0.00614	0.00624	CcSEcCtD
Sitagliptin—Renal failure—Telbivudine—hepatitis B	0.00612	0.00621	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Telbivudine—hepatitis B	0.0061	0.0062	CcSEcCtD
Sitagliptin—Mental disorder—Entecavir—hepatitis B	0.00596	0.00605	CcSEcCtD
Sitagliptin—Malnutrition—Entecavir—hepatitis B	0.00592	0.00601	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Telbivudine—hepatitis B	0.00588	0.00598	CcSEcCtD
Sitagliptin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00577	0.00587	CcSEcCtD
Sitagliptin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00569	0.00578	CcSEcCtD
Sitagliptin—Back pain—Adefovir Dipivoxil—hepatitis B	0.00559	0.00568	CcSEcCtD
Sitagliptin—Hypoaesthesia—Telbivudine—hepatitis B	0.00556	0.00565	CcSEcCtD
Sitagliptin—Pharyngitis—Telbivudine—hepatitis B	0.00554	0.00563	CcSEcCtD
Sitagliptin—Connective tissue disorder—Telbivudine—hepatitis B	0.00549	0.00558	CcSEcCtD
Sitagliptin—Gastroenteritis—Lamivudine—hepatitis B	0.00513	0.00522	CcSEcCtD
Sitagliptin—Cough—Adefovir Dipivoxil—hepatitis B	0.00504	0.00512	CcSEcCtD
Sitagliptin—Mediastinal disorder—Telbivudine—hepatitis B	0.00503	0.00511	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.005	0.00508	CcSEcCtD
Sitagliptin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00492	0.00499	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00488	0.00496	CcSEcCtD
Sitagliptin—Malnutrition—Telbivudine—hepatitis B	0.00486	0.00494	CcSEcCtD
Sitagliptin—Anaphylactic shock—Entecavir—hepatitis B	0.00483	0.00491	CcSEcCtD
Sitagliptin—Infection—Entecavir—hepatitis B	0.0048	0.00488	CcSEcCtD
Sitagliptin—Renal impairment—Lamivudine—hepatitis B	0.00478	0.00486	CcSEcCtD
Sitagliptin—Nervous system disorder—Entecavir—hepatitis B	0.00474	0.00481	CcSEcCtD
Sitagliptin—Back pain—Telbivudine—hepatitis B	0.0047	0.00478	CcSEcCtD
Sitagliptin—Skin disorder—Entecavir—hepatitis B	0.00469	0.00477	CcSEcCtD
Sitagliptin—DPP4—blood plasma—hepatitis B	0.00469	0.297	CbGeAlD
Sitagliptin—Muscle spasms—Telbivudine—hepatitis B	0.00467	0.00475	CcSEcCtD
Sitagliptin—Hypoglycaemia—Lamivudine—hepatitis B	0.00466	0.00474	CcSEcCtD
Sitagliptin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00462	0.0047	CcSEcCtD
Sitagliptin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00458	0.00465	CcSEcCtD
Sitagliptin—Ill-defined disorder—Telbivudine—hepatitis B	0.00451	0.00458	CcSEcCtD
Sitagliptin—Migraine—Lamivudine—hepatitis B	0.00448	0.00455	CcSEcCtD
Sitagliptin—Malaise—Telbivudine—hepatitis B	0.00438	0.00445	CcSEcCtD
Sitagliptin—Insomnia—Entecavir—hepatitis B	0.00437	0.00444	CcSEcCtD
Sitagliptin—Somnolence—Entecavir—hepatitis B	0.00429	0.00436	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00429	0.00436	CcSEcCtD
Sitagliptin—Dyspepsia—Entecavir—hepatitis B	0.00425	0.00432	CcSEcCtD
Sitagliptin—Cough—Telbivudine—hepatitis B	0.00424	0.00431	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Entecavir—hepatitis B	0.00417	0.00424	CcSEcCtD
Sitagliptin—Fatigue—Entecavir—hepatitis B	0.00416	0.00423	CcSEcCtD
Sitagliptin—Abdominal pain upper—Lamivudine—hepatitis B	0.00416	0.00422	CcSEcCtD
Sitagliptin—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00415	0.00421	CcSEcCtD
Sitagliptin—Arthralgia—Telbivudine—hepatitis B	0.00414	0.00421	CcSEcCtD
Sitagliptin—Myalgia—Telbivudine—hepatitis B	0.00414	0.00421	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00411	0.00418	CcSEcCtD
Sitagliptin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0041	0.00416	CcSEcCtD
Sitagliptin—Discomfort—Telbivudine—hepatitis B	0.00409	0.00416	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00407	0.00413	CcSEcCtD
Sitagliptin—Nasopharyngitis—Lamivudine—hepatitis B	0.00407	0.00413	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Entecavir—hepatitis B	0.00395	0.00401	CcSEcCtD
Sitagliptin—Influenza—Lamivudine—hepatitis B	0.00393	0.004	CcSEcCtD
Sitagliptin—Nervous system disorder—Telbivudine—hepatitis B	0.00389	0.00395	CcSEcCtD
Sitagliptin—Pancreatitis—Lamivudine—hepatitis B	0.00386	0.00392	CcSEcCtD
Sitagliptin—Skin disorder—Telbivudine—hepatitis B	0.00385	0.00392	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00385	0.00392	CcSEcCtD
Sitagliptin—Abdominal pain—Entecavir—hepatitis B	0.00382	0.00388	CcSEcCtD
Sitagliptin—Bronchitis—Lamivudine—hepatitis B	0.00378	0.00384	CcSEcCtD
Sitagliptin—Abdominal discomfort—Lamivudine—hepatitis B	0.00377	0.00383	CcSEcCtD
Sitagliptin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00373	0.00379	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00361	0.00367	CcSEcCtD
Sitagliptin—Insomnia—Telbivudine—hepatitis B	0.00359	0.00365	CcSEcCtD
Sitagliptin—Hyperglycaemia—Lamivudine—hepatitis B	0.00355	0.0036	CcSEcCtD
Sitagliptin—Depression—Lamivudine—hepatitis B	0.0035	0.00355	CcSEcCtD
Sitagliptin—Dyspepsia—Telbivudine—hepatitis B	0.00349	0.00355	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00348	0.00353	CcSEcCtD
Sitagliptin—Asthenia—Entecavir—hepatitis B	0.00347	0.00352	CcSEcCtD
Sitagliptin—Renal failure—Lamivudine—hepatitis B	0.00345	0.0035	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Lamivudine—hepatitis B	0.00344	0.00349	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00343	0.00348	CcSEcCtD
Sitagliptin—Fatigue—Telbivudine—hepatitis B	0.00342	0.00348	CcSEcCtD
Sitagliptin—Pain—Telbivudine—hepatitis B	0.00339	0.00345	CcSEcCtD
Sitagliptin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00338	0.00344	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Lamivudine—hepatitis B	0.00332	0.00337	CcSEcCtD
Sitagliptin—Diarrhoea—Entecavir—hepatitis B	0.0033	0.00336	CcSEcCtD
Sitagliptin—Sinusitis—Lamivudine—hepatitis B	0.00329	0.00334	CcSEcCtD
Sitagliptin—Feeling abnormal—Telbivudine—hepatitis B	0.00327	0.00332	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Telbivudine—hepatitis B	0.00324	0.0033	CcSEcCtD
Sitagliptin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00322	0.00328	CcSEcCtD
Sitagliptin—Dizziness—Entecavir—hepatitis B	0.00319	0.00325	CcSEcCtD
Sitagliptin—Abdominal pain—Telbivudine—hepatitis B	0.00314	0.00319	CcSEcCtD
Sitagliptin—Hypoaesthesia—Lamivudine—hepatitis B	0.00313	0.00318	CcSEcCtD
Sitagliptin—Pharyngitis—Lamivudine—hepatitis B	0.00312	0.00317	CcSEcCtD
Sitagliptin—Connective tissue disorder—Lamivudine—hepatitis B	0.00309	0.00314	CcSEcCtD
Sitagliptin—Vomiting—Entecavir—hepatitis B	0.00307	0.00312	CcSEcCtD
Sitagliptin—Rash—Entecavir—hepatitis B	0.00305	0.00309	CcSEcCtD
Sitagliptin—Dermatitis—Entecavir—hepatitis B	0.00304	0.00309	CcSEcCtD
Sitagliptin—Headache—Entecavir—hepatitis B	0.00303	0.00307	CcSEcCtD
Sitagliptin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.003	0.00304	CcSEcCtD
Sitagliptin—Erythema multiforme—Lamivudine—hepatitis B	0.00298	0.00302	CcSEcCtD
Sitagliptin—Rash—Adefovir Dipivoxil—hepatitis B	0.00297	0.00302	CcSEcCtD
Sitagliptin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00297	0.00302	CcSEcCtD
Sitagliptin—Headache—Adefovir Dipivoxil—hepatitis B	0.00295	0.003	CcSEcCtD
Sitagliptin—Nausea—Entecavir—hepatitis B	0.00287	0.00292	CcSEcCtD
Sitagliptin—Asthenia—Telbivudine—hepatitis B	0.00285	0.00289	CcSEcCtD
Sitagliptin—Immune system disorder—Lamivudine—hepatitis B	0.00284	0.00289	CcSEcCtD
Sitagliptin—Mediastinal disorder—Lamivudine—hepatitis B	0.00284	0.00288	CcSEcCtD
Sitagliptin—Nausea—Adefovir Dipivoxil—hepatitis B	0.0028	0.00284	CcSEcCtD
Sitagliptin—Malnutrition—Lamivudine—hepatitis B	0.00274	0.00278	CcSEcCtD
Sitagliptin—Diarrhoea—Telbivudine—hepatitis B	0.00271	0.00276	CcSEcCtD
Sitagliptin—Flatulence—Lamivudine—hepatitis B	0.0027	0.00274	CcSEcCtD
Sitagliptin—Tension—Lamivudine—hepatitis B	0.00269	0.00273	CcSEcCtD
Sitagliptin—Nervousness—Lamivudine—hepatitis B	0.00266	0.0027	CcSEcCtD
Sitagliptin—Back pain—Lamivudine—hepatitis B	0.00265	0.00269	CcSEcCtD
Sitagliptin—Muscle spasms—Lamivudine—hepatitis B	0.00263	0.00268	CcSEcCtD
Sitagliptin—Dizziness—Telbivudine—hepatitis B	0.00262	0.00267	CcSEcCtD
Sitagliptin—Ill-defined disorder—Lamivudine—hepatitis B	0.00254	0.00258	CcSEcCtD
Sitagliptin—Vomiting—Telbivudine—hepatitis B	0.00252	0.00256	CcSEcCtD
Sitagliptin—Angioedema—Lamivudine—hepatitis B	0.0025	0.00254	CcSEcCtD
Sitagliptin—Rash—Telbivudine—hepatitis B	0.0025	0.00254	CcSEcCtD
Sitagliptin—Dermatitis—Telbivudine—hepatitis B	0.0025	0.00254	CcSEcCtD
Sitagliptin—Headache—Telbivudine—hepatitis B	0.00249	0.00253	CcSEcCtD
Sitagliptin—Malaise—Lamivudine—hepatitis B	0.00247	0.00251	CcSEcCtD
Sitagliptin—Vertigo—Lamivudine—hepatitis B	0.00246	0.0025	CcSEcCtD
Sitagliptin—Cough—Lamivudine—hepatitis B	0.00239	0.00243	CcSEcCtD
Sitagliptin—Nausea—Telbivudine—hepatitis B	0.00236	0.00239	CcSEcCtD
Sitagliptin—Arthralgia—Lamivudine—hepatitis B	0.00233	0.00237	CcSEcCtD
Sitagliptin—Myalgia—Lamivudine—hepatitis B	0.00233	0.00237	CcSEcCtD
Sitagliptin—Anxiety—Lamivudine—hepatitis B	0.00232	0.00236	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00232	0.00235	CcSEcCtD
Sitagliptin—Discomfort—Lamivudine—hepatitis B	0.0023	0.00234	CcSEcCtD
Sitagliptin—Dry mouth—Lamivudine—hepatitis B	0.00228	0.00232	CcSEcCtD
Sitagliptin—CYP2C8—blood plasma—hepatitis B	0.00226	0.143	CbGeAlD
Sitagliptin—Anaphylactic shock—Lamivudine—hepatitis B	0.00224	0.00227	CcSEcCtD
Sitagliptin—Infection—Lamivudine—hepatitis B	0.00222	0.00226	CcSEcCtD
Sitagliptin—Nervous system disorder—Lamivudine—hepatitis B	0.00219	0.00223	CcSEcCtD
Sitagliptin—Skin disorder—Lamivudine—hepatitis B	0.00217	0.00221	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00204	0.00207	CcSEcCtD
Sitagliptin—Insomnia—Lamivudine—hepatitis B	0.00202	0.00205	CcSEcCtD
Sitagliptin—Somnolence—Lamivudine—hepatitis B	0.00199	0.00202	CcSEcCtD
Sitagliptin—Dyspepsia—Lamivudine—hepatitis B	0.00197	0.002	CcSEcCtD
Sitagliptin—Decreased appetite—Lamivudine—hepatitis B	0.00194	0.00198	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00193	0.00196	CcSEcCtD
Sitagliptin—Fatigue—Lamivudine—hepatitis B	0.00193	0.00196	CcSEcCtD
Sitagliptin—Constipation—Lamivudine—hepatitis B	0.00191	0.00194	CcSEcCtD
Sitagliptin—Pain—Lamivudine—hepatitis B	0.00191	0.00194	CcSEcCtD
Sitagliptin—Feeling abnormal—Lamivudine—hepatitis B	0.00184	0.00187	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Lamivudine—hepatitis B	0.00183	0.00186	CcSEcCtD
Sitagliptin—Urticaria—Lamivudine—hepatitis B	0.00178	0.0018	CcSEcCtD
Sitagliptin—Abdominal pain—Lamivudine—hepatitis B	0.00177	0.0018	CcSEcCtD
Sitagliptin—DPP4—blood—hepatitis B	0.00172	0.109	CbGeAlD
Sitagliptin—Hypersensitivity—Lamivudine—hepatitis B	0.00165	0.00167	CcSEcCtD
Sitagliptin—Asthenia—Lamivudine—hepatitis B	0.0016	0.00163	CcSEcCtD
Sitagliptin—Diarrhoea—Lamivudine—hepatitis B	0.00153	0.00155	CcSEcCtD
Sitagliptin—CYP3A4—blood plasma—hepatitis B	0.00153	0.0968	CbGeAlD
Sitagliptin—Dizziness—Lamivudine—hepatitis B	0.00148	0.0015	CcSEcCtD
Sitagliptin—Vomiting—Lamivudine—hepatitis B	0.00142	0.00144	CcSEcCtD
Sitagliptin—Rash—Lamivudine—hepatitis B	0.00141	0.00143	CcSEcCtD
Sitagliptin—Dermatitis—Lamivudine—hepatitis B	0.00141	0.00143	CcSEcCtD
Sitagliptin—Headache—Lamivudine—hepatitis B	0.0014	0.00142	CcSEcCtD
Sitagliptin—DPP4—liver—hepatitis B	0.00134	0.085	CbGeAlD
Sitagliptin—Nausea—Lamivudine—hepatitis B	0.00133	0.00135	CcSEcCtD
Sitagliptin—ABCB1—blood plasma—hepatitis B	0.00108	0.0685	CbGeAlD
Sitagliptin—CYP2C8—blood—hepatitis B	0.000827	0.0523	CbGeAlD
Sitagliptin—CYP2C8—liver—hepatitis B	0.000647	0.0409	CbGeAlD
Sitagliptin—CYP3A4—blood—hepatitis B	0.00056	0.0354	CbGeAlD
Sitagliptin—CYP3A4—liver—hepatitis B	0.000438	0.0277	CbGeAlD
Sitagliptin—ABCB1—blood—hepatitis B	0.000397	0.0251	CbGeAlD
Sitagliptin—ABCB1—liver—hepatitis B	0.00031	0.0196	CbGeAlD
